Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis

INTRODUCTION: Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib monotherapy was previously shown to inhibit structural damage, reduce clinical signs and symptoms of RA, and improve physical functioning over 24 months in methotrexate (MTX)-naive...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:RMD Open
Glavni autori: Fleischmann, Roy M, Huizinga, Tom W J, Kavanaugh, Arthur F, Wilkinson, Bethanie, Kwok, Kenneth, DeMasi, Ryan, van Vollenhoven, Ronald F
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Rheumatoid Arthritis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4964179/
https://ncbi.nlm.nih.gov/pubmed/27493790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2016-000262
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items